|
|
Volumn 304, Issue 5676, 2004, Pages 1437-
|
|
Vaccine development with a distinctly Chinese flavor
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
LIVE VACCINE;
VIRUS VECTOR;
RECOMBINANT VACCINE;
VIRUS PROTEIN;
VIRUS VACCINE;
DRUG DEVELOPMENT;
VACCINE;
ACHIEVEMENT;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CHINA;
DISEASE MODEL;
DRUG DESIGN;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MACACA;
MEDICAL RESEARCH;
NONHUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
SIMIAN IMMUNODEFICIENCY VIRUS;
VACCINIA VIRUS;
VIRUS STRAIN;
ANIMAL;
ARTICLE;
EQUINE INFECTIOUS ANEMIA VIRUS;
GENETICS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
IMMUNIZATION;
IMMUNOLOGY;
MONKEY DISEASE;
PATHOGENICITY;
HUMAN IMMUNODEFICIENCY VIRUS;
MACACA;
SIMIAE;
SIMIAN IMMUNODEFICIENCY VIRUS;
VACCINIA VIRUS;
AIDS VACCINES;
ANIMALS;
CHINA;
DISEASE MODELS, ANIMAL;
HIV;
HIV INFECTIONS;
HUMANS;
IMMUNIZATION, SECONDARY;
INFECTIOUS ANEMIA VIRUS, EQUINE;
MACACA;
SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME;
SIMIAN IMMUNODEFICIENCY VIRUS;
VACCINES, ATTENUATED;
VACCINES, SYNTHETIC;
VIRAL PROTEINS;
VIRAL VACCINES;
|
|
EID: 2642526952
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.304.5676.1437 Document Type: Short Survey |
|
Times cited : (10)
|
|
References (0)
|